NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

10836	Companies
235277	Keywords
164215	Articles
126032	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 05/21/2025 at 22:20, 1 year 2 months ago

Nanobiotix Reports Q1 2025 Achievements and Financial Status

Biotechnology Financial Update NANOBIOTIX JNJ-1900 Cancer Trials
BRIEF

published on 05/21/2025 at 22:20, 1 year 2 months ago

Nanobiotix publie ses résultats et sa situation financière pour le premier trimestre 2025

Biotechnologie Mise À Jour Financière NANOBIOTIX JNJ-1900 Essais Sur Le Cancer
PRESS RELEASE

published on 05/21/2025 at 22:15, 1 year 2 months ago

Nanobiotix Provides First Quarter 2025 Operational and Financial Update
Nanobiotix provides operational and financial update for Q1 2025, including CONVERGE study dosing, financial strengthening, and €39.8M cash reserves as of March 31, 2025

Operational Update Financial Update Cash Reserves NANOBIOTIX CONVERGE Study
PRESS RELEASE

published on 05/21/2025 at 22:15, 1 year 2 months ago

Nanobiotix fait le point sur sa trésorerie et son activité opérationnelle du premier trimestre 2025
Nanobiotix annonce ses progrès opérationnels et sa trésorerie pour le premier trimestre 2025, avec un renforcement financier et des avancées dans le traitement du cancer du poumon

Trésorerie Études Cliniques NANOBIOTIX Cancer Du Poumon JNJ-1900
BRIEF

published on 04/14/2025 at 22:20, 1 year 4 months ago

Nanobiotix : Mise à jour mensuelle des droits de vote et actions

Droits De Vote Euronext Capital Social Nasdaq NANOBIOTIX
BRIEF

published on 04/14/2025 at 22:20, 1 year 4 months ago

Nanobiotix: Monthly update of voting rights and shares

Share Capital Voting Rights Euronext Nasdaq NANOBIOTIX
PRESS RELEASE

published on 04/14/2025 at 22:15, 1 year 4 months ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Communiqué de presse mensuel sur le nombre total de droits de vote et d'actions de Nanobiotix. Informations boursières et financières détaillées. Présentation de l'entreprise et de ses activités

Innovation Euronext Paris Droits De Vote Biotechnologie NANOBIOTIX
PRESS RELEASE

published on 04/14/2025 at 22:15, 1 year 4 months ago

Voting Rights and Shares Capital of the Company
Nanobiotix reports voting rights and shares capital updates. The late-stage biotech company aims to improve treatment outcomes through innovative therapies

Voting Rights Shares Capital Biotechnology Company NANOBIOTIX Treatment Outcomes
BRIEF

published on 03/27/2025 at 21:20, 1 year 4 months ago

Nanobiotix Unveils Phase 1 Data on NSCLC Therapy

NSCLC NBTXR3 Phase 1 Study Radioenhancer Clinical Trial Data
BRIEF

published on 03/27/2025 at 21:20, 1 year 4 months ago

Nanobiotix dévoile les données de phase 1 sur le traitement du cancer du poumon non à petites cellules

Étude De Phase 1 NBTXR3 CPNPC Radioenhancer Données Des Essais Cliniques

Accesswire

Published on 08/15/2026 at 00:50, 22 hours 33 minutes ago

Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 23 hours 8 minutes ago

Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 23 hours 38 minutes ago

AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 23 hours 58 minutes ago

NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 1 day ago

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

View all ACCESSWIRE

EQS Group

Published on 08/15/2026 at 15:05, 8 hours 17 minutes ago

Brook Gaming Officially Launches Sniper 2 Flagship Keyboard and Mouse Converter for Cross-Platform Console Gaming
Published on 08/15/2026 at 08:05, 15 hours 17 minutes ago

SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:29, 1 day 4 hours ago

Designated Persons Notifications
Published on 08/14/2026 at 18:29, 1 day 4 hours ago

Designated Persons Notifications
Published on 08/14/2026 at 18:15, 1 day 5 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 08/13/2026 at 18:00, 2 days 5 hours ago

Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 4 days 5 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 4 days 5 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 5 days 5 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 5 days 5 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

View all LES ECHOS COMFI WIRE